Centers for Disease Control and Prevention
The WHO and the US are monitoring a New Variant of the Coronavirus
The World Health Organization (WHO) and the United States are monitoring a new variant of the SARS-CoV-2 coronavirus, reported AFP. The potential significance of the numerous mutations is currently unknown.
YouTube to certify healthcare providers’ accounts
Doctors, nurses and other healthcare professionals can apply to have their YouTube channels certified, the video sharing platform said on Oct. 27, in a push to limit misinformation on the site.
- Read more about YouTube to certify healthcare providers’ accounts
- Log in to post comments
Pfizer COVID-19 pill showed no benefit in younger adults: Study
Pfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published on Aug. 24.
Baby formula shortage highlights racial disparities
Capri Isidoro broke down in tears sitting on a chair at the office of a lactation consultant. The mother of two had been struggling to breastfeed her 1-month-old daughter ever since she was born, when the hospital gave the baby formula first without consulting her on her desire to breastfeed.
US preparing to deploy monkeypox vaccines amid more probable cases
The United States is preparing to give monkeypox vaccines to close contacts of people infected and to deploy treatments, with five cases now either confirmed or probable and the number likely to rise, officials said Monday.
Studies in the United States Point to the Need for a Third Dose of Covid Vaccine
According to studies by the Centers for Disease Control and Prevention in the United States, vaccine protection has dropped to 94% during the Delta variant and to 82% during Omicron. These are the first 3 major studies looking at the extent to which vaccines protect against Omicron.
US Authorities Preparing for Possible Outbreaks of Coronavirus due to the "Omicron" Variant
The administration of US President Joe Biden is developing plans to detect possible outbreaks of the disease across the country in connection with the discovery of the coronavirus variant Omicron. This was reported by the American newspaper Politico, citing sources among the authorities.
The United States has Approved the Pfizer Vaccine for Children Aged 5 to 11 Years.
The US health authorities have approved the use of the COVID-19 vaccine by BioNTech / Pfizer for children between 5 and 11 years of age. The first doses may be given on Wednesday, Reuters reported.
US gives final approval of Pfizer’s COVID vaccine for children aged 5-11
The United States can now start giving children aged 5-11 the Pfizer-BioNtech COVID vaccine, U.S. health authorities said on Nov. 2 in a move hailed by President Joe Biden as a "turning point" in the fight against the pandemic.
US authorizes Pfizer Covid vaccine for children 5-11
The United States on Oct. 29 authorized the Pfizer Covid vaccine for children aged five-to-11, paving the way for 28 million young Americans to soon get immunized.